US FDA to Review Eli Lilly’s Donanemab for Early Alzheimer’s Treatment
The meeting is set to be held on June 10, 2024
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Steriline to exhibit its Robotic Vial Filling Machine at ACHEMA 2024
Aims to upgrade its zero loss philosophy
Some action points for the next PM
As we vote in our next set of policymakers, a reality check shows that while the pharma sector in India has come a long way,…
Gland Pharma receives USFDA approval for Edaravone Injection
The product is used to treat amyotrophic lateral sclerosis (ALS)
APAC leads in asthma clinical trials between 2019-2023: GlobalData
China, India, and South Korea among the top three countries
Indian Pharma Urges US-India partnership for affordable Medicine
IPA cites new IQVIA Institute study demonstrating India’s vital contribution to the U.S. healthcare
Sharp spike in pharma, healthcare funding in April 2024, touches $332 mn
API Holdings secured the biggest deal ($216 million), followed by La Renon ( $70 million) and Biodeal Pharmaceuticals ($13.2…
Lupin Receives Approval from U.S. FDA for Travoprost Ophthalmic Solution USP
It is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.
PHARMAP 2024 held in Amsterdam, marks its fourth edition
The event brought together over 330 professionals from across the industry’s value chain
Research led by Sydney University develop nanotech-based oral insulin medicine
The new nano carrier could help people with diabetes avoid side-effects linked to insulin injections such as hypoglycemia, inform…
Chinese companies lead ADC development pipeline: GlobalData
A significant level of increase is seen in Chinese companies within the Antibody-drug conjugates market.
Alembic Pharmaceuticals receives an EIR for its oncology formulation facility
According to the company’s statement, all EIRs are in place for their USFDA facilities
Results show potential of J&J’s TAR-210 to transform treatment of bladder cancer with FGFR…
Phase 1 trial shows 90 per cent recurrence-free survival and 90 per cent complete response in patients with high-risk and…
Lupin launches biosimilar Etanercept in Canada
Rymti is indicated for the treatment of moderate to severe active rheumatoid arthritis, juvenile idiopathic arthritis, active and…
DP World establishes new warehouse in Goa
The facility is compliant with all safety standards and provides connectivity to the Goa-Bangalore-Pune highway
Naprod renews EU-GMP certification for Palghar facility
The audit was conducted in December 2023 by The National Institute of Pharmacy and Nutrition (OGYÉI), Hungary
Emcure unveils campaign ‘Cure and Beyond’
The new corporate campaign featuring MS Dhoni aims to support, and educate people
WHO, THSTI launch e-learning course on rational use of medicines for pharmacists
This course comprises various modules such as the basic concept of rational use of Medicines, pharmacy practice regulation and…
Bayer secures full ownership of Bayer Zydus Pharma, acquires remaining 25 per cent stakes
The 50:50 joint venture was established on January 28, 2011, for the sales and marketing of pharmaceutical products in India
Akums introduces DCGI approved FDC medication
Amlodipine, Telmisartan & Metoprolol (ER) film coated tablets for treatment of resistant Hypertension